These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20378293)

  • 1. Molecular imaging contrast media for visualization of liver function.
    Yoshinori M; Masaharu M; Yuri H; Sayoko N; Nao S; Makoto H
    Magn Reson Imaging; 2010 Jun; 28(5):708-15. PubMed ID: 20378293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes.
    Ketkar-Atre A; Struys T; Dresselaers T; Hodenius M; Mannaerts I; Ni Y; Lambrichts I; Van Grunsven LA; De Cuyper M; Himmelreich U
    Biomaterials; 2014 Jan; 35(3):1015-24. PubMed ID: 24210051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes.
    Ise H; Sugihara N; Negishi N; Nikaido T; Akaike T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):172-82. PubMed ID: 11444822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes.
    McVicker BL; Tuma DJ; Kubik JA; Hindemith AM; Baldwin CR; Casey CA
    Hepatology; 2002 Dec; 36(6):1478-87. PubMed ID: 12447874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver.
    Rotundo RF; Rebres RA; Mckeown-Longo PJ; Blumenstock FA; Saba TM
    Hepatology; 1998 Aug; 28(2):475-85. PubMed ID: 9696014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lobular expression of the rat asialoglycoprotein receptor is regulated at the posttranscriptional level.
    Massimi M; Leoni S; Devirgiliis LC
    Liver Int; 2005 Feb; 25(1):184-93. PubMed ID: 15698417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of asialoglycoprotein receptor expression in the proliferative state of hepatocytes.
    Hirose S; Ise H; Uchiyama M; Cho CS; Akaike T
    Biochem Biophys Res Commun; 2001 Sep; 287(3):675-81. PubMed ID: 11563848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hollow fiber bioreactor: new development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging.
    Planchamp C; Ivancevic MK; Pastor CM; Vallée JP; Pochon S; Terrier F; Mayer JM; Reist M
    Biotechnol Bioeng; 2004 Mar; 85(6):656-65. PubMed ID: 14966807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cell labelling with MRI contrast agents.
    Modo M; Meade TJ; Mitry RR
    Methods Mol Biol; 2009; 481():207-19. PubMed ID: 19096799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions.
    Al-Saeed O; Ismail M; Athyal RP; Rudwan M; Khafajee S
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):366-72. PubMed ID: 19695043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.